ANAS High Technologies Park

China based CMS joins BaseLaunch as latest partner

Retrieved on: 
Wednesday, September 22, 2021
Biotechnology, Therapy, Partnership, ANAS High Technologies Park, Efficiency, Hong Kong Stock Exchange, Administration, Health, CMS, CSL Behring, Marketing, Wuxi, Alloy, Roivant Sciences, Basel-Landschaft, AstraZeneca, KPMG, Johnson & Johnson, Beauty, Innovation, Dermatology, Safety, Ecosystem, Interest, Fine chemical

CMS has a long history of successful partnership with a range of companies from biotechnology companies to global pharma, and has collaborations with AstraZeneca and a venture arm based in Cambridge UK.

Key Points: 
  • CMS has a long history of successful partnership with a range of companies from biotechnology companies to global pharma, and has collaborations with AstraZeneca and a venture arm based in Cambridge UK.
  • Stephan Emmerth, Director Business Development & Operations at BaseLaunch, added: "We are very excited to be further expanding our partnership into Asia Pacific with CMS.
  • This is the first Chinese company to partner with BaseLaunch and CMS's first partnership with an accelerator.
  • Recently, BaseLaunch has added two more companies to its portfolio with several more deals expected to close in the coming months.

China based CMS joins BaseLaunch as latest partner

Retrieved on: 
Wednesday, September 22, 2021
Biotechnology, Therapy, Partnership, ANAS High Technologies Park, Efficiency, Hong Kong Stock Exchange, Administration, Health, CMS, CSL Behring, Marketing, Wuxi, Alloy, Roivant Sciences, Basel-Landschaft, AstraZeneca, KPMG, Johnson & Johnson, Beauty, Innovation, Dermatology, Safety, Ecosystem, Interest, Fine chemical

BASEL, Switzerland, Sept. 22, 2021 /PRNewswire/ -- BaseLaunch, the Basel Area-based biotech venture accelerator and incubator, today announces that China Medical System Holdings Limited ("CMS"), an innovation-driven specialty pharma with a focus on sales and marketing in China, has become a partner to further strengthen BaseLaunch`s industry ties fueling its company building activities.

Key Points: 
  • CMS has a long history of successful partnership with a range of companies from biotechnology companies to global pharma, and has collaborations with AstraZeneca and a venture arm based in Cambridge UK.
  • Stephan Emmerth, Director Business Development & Operations at BaseLaunch, added: "We are very excited to be further expanding our partnership into Asia Pacific with CMS.
  • This is the first Chinese company to partner with BaseLaunch and CMS's first partnership with an accelerator.
  • Recently, BaseLaunch has added two more companies to its portfolio with several more deals expected to close in the coming months.